Teladoc Health (NYSE:TDOC) Price Target Lowered to $10.00 at Evercore ISI

Teladoc Health (NYSE:TDOC) had its price target dropped by equities researchers at Evercore ISI from $14.00 to $10.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “in-line” rating on the health services provider’s stock. Evercore ISI’s price objective points to a potential upside of 11.67% from the stock’s current price.

Several other equities analysts have also issued reports on the company. Oppenheimer decreased their target price on Teladoc Health from $26.00 to $21.00 and set an “outperform” rating on the stock in a research note on Friday, April 26th. JPMorgan Chase & Co. decreased their target price on Teladoc Health from $19.00 to $16.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 21st. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Friday, April 26th. TD Cowen decreased their target price on Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research note on Friday, April 26th. Finally, Bank of America decreased their target price on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating on the stock in a research note on Tuesday, May 14th. Thirteen analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $17.97.

Teladoc Health Stock Performance

Shares of Teladoc Health stock opened at $8.96 on Tuesday. Teladoc Health has a 52 week low of $8.73 and a 52 week high of $30.41. The business’s fifty day simple moving average is $10.93 and its 200-day simple moving average is $15.09. The firm has a market cap of $1.52 billion, a PE ratio of -6.35 and a beta of 0.94. The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same period last year, the company earned ($0.37) EPS. The business’s revenue for the quarter was up 2.7% on a year-over-year basis. Equities analysts forecast that Teladoc Health will post -1.05 earnings per share for the current year.

Insider Activity

In other news, insider Laizer Kornwasser sold 10,411 shares of the stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, Director Karen L. Daniel sold 9,834 shares of the firm’s stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total transaction of $117,024.60. Following the transaction, the director now owns 36,995 shares in the company, valued at approximately $440,240.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Laizer Kornwasser sold 10,411 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the transaction, the insider now owns 86,070 shares in the company, valued at approximately $1,092,228.30. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 32,592 shares of company stock worth $397,064. 0.95% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Hexagon Capital Partners LLC grew its stake in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after buying an additional 1,065 shares during the last quarter. Allianz Asset Management GmbH lifted its position in Teladoc Health by 15.4% during the 4th quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock worth $13,021,000 after acquiring an additional 80,805 shares during the period. Vanguard Group Inc. lifted its position in Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider’s stock worth $377,451,000 after acquiring an additional 1,855,480 shares during the period. Pale Fire Capital SE acquired a new stake in Teladoc Health during the 4th quarter worth approximately $8,960,000. Finally, Jump Financial LLC lifted its position in Teladoc Health by 400.9% during the 4th quarter. Jump Financial LLC now owns 112,421 shares of the health services provider’s stock worth $2,423,000 after acquiring an additional 89,975 shares during the period. Hedge funds and other institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.